GENERIC NAME | Cinacalcet.HCl Tablets |
STRUCTURE | ((R)-N-(3-(3-(trifluoromethoxy)phenyl)proyl)-1-(1-naphthyl)ethylamine |
INDICATION'S |
APPROVED INDICATIONS - HyperCalemia of ParaThyroid Cancer - Sec. HyperParaThyroidism>End Stage Re nal Disease - Sec. HyperParaThyroidism>CKD Dialysis NON-APPROVED INDICATIONS - Primary HyperParaThyroidism (Ph. II) - Sec. HyperParaThyroidism>CKD>Stages 3 & 4) (Ph. III) |
MARKETER'S COUNTRY | Europe |
UPDATE | 01.26.06 |
COMPANY | This data is not available for free |
LICENSEE | Co |
LICENSOR | This data is not available for free |
PATENT NUMBER | This data is not available for free |
Want more information ? Interested in the hidden information ? Click here and do your request. |